1-1 of 1
Alison K. Holcroft
Close
Sort by
Journal Articles

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML

Claire M. Lucas, Laura J. Scott, Natasha Carmell, Alison K. Holcroft, Robert K. Hills, Alan K. Burnett, Richard E. Clark
Journal: Blood Advances
Blood Adv (2018) 2 (9): 964–968.
https://doi.org/10.1182/bloodadvances.2017013615
Published: 2018
Includes: Supplemental data